SCHEMBL4018872

SCHEMBL4018872

CCCCCCCCCCCCCCC(CCCCCCCCCCCCCC)C(C)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.54
GPR84 Q9NQS5 7/20 0.48
FFAR1 O14842 2/20 0.48
LMNA P02545 2/20 0.48
OPRM1 P35372 1/20 0.46
CYP2D6 P10635 2/20 0.45
GMNN O75496 1/20 0.45
POLB P06746 1/20 0.45
THPO P40225 1/20 0.45
MTOR P42345 1/20 0.45
BLM P54132 1/20 0.45
KDM4E B2RXH2 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPT P10636 1/20 0.45
CETP P11597 1/20 0.45
HTT P42858 1/20 0.45
UBE2N P61088 1/20 0.45
FFAR4 Q5NUL3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29269912 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL29269957 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL29270000 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL29269913 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL30873138 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL18589805 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL18893466 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL29269982 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL29270010 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1
SCHEMBL29270080 1.00 SPHK1 (0.54) SPHK1GPR84FFAR1LMNAOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059257-A2 USE OF GLYCOLIPIDS AS ADJUVANTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2009-05-20 EP disclosed
WO-2008028667-A2 USE OF GLYCOLIPIDS AS ADJUVANTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2008-03-13 WO disclosed